News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Exodus will cut 25% of its global workforce.
  • Exodus will refocus on full‑stack stablecoin payments and integrate Monavate and Baanx.
  • Exodus expects $10–$13 million in annualized savings starting in 2027.
  • Erasca shares fell after legal and clinical setbacks in its RAS inhibitor program.
  • Erasca retains a modality‑agnostic RAS/MAPK pipeline and fresh capital.
  • MKDWELL will acquire Landvision for $240 million in newly issued shares to enter smart‑home IoT.
  • The MKDWELL deal includes staggered seller lock‑ups and targets closing by August 2026.

Latest Articles

Where Space Exists, Soccer Follows: Community Pitches Across Mexico

Where Space Exists, Soccer Follows: Community Pitches Across Mexico

Across regions of Mexico hosting the World Cup, communities convert marginal spaces into informal soccer pitches. From an impoverished Monterrey neighborhood to a crater-turned-field outside Mexico City and the canal boroughs of Xochimilco, residents sustain the sport with improvised facilities that serve as social hubs but can also strain local en…

Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases

Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases

Cartesian Therapeutics has announced a strategic licensing agreement with WestGene Biopharma to combine Cartesian's mRNA CAR-T payload technology with WestGene's targeted lipid nanoparticle platform for in vivo delivery. The partnership aims to initiate Phase 1 clinical trials in the second half of 2026 for generalized myasthenia gravis patients, w…

Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration

Kymera Therapeutics Announces First Participant Dosed in Phase 1 Trial of Oral IRAK4 Degrader, KT-485, and Milestone Achievement Under Sanofi Collaboration

Kymera Therapeutics announced the dosing of the first participant in the Phase 1 trial of KT-485, an oral IRAK4 degrader for immuno-inflammatory diseases, conducted by partner Sanofi. This milestone triggered a $20 million payment from Sanofi to Kymera under their collaboration, which includes potential total milestones of up to $975 million. The t…

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference

DBV Technologies Revises Participation in the Goldman Sachs 47th Annual Global Healthcare Conference

DBV Technologies announced that while its management will participate in one-on-one investor meetings at the Goldman Sachs 47th Annual Global Healthcare Conference, CEO Daniel Tassé will not attend the previously scheduled fireside chat due to travel disruptions. The company focuses on developing epicutaneous immunotherapy treatments for food aller…

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Aclarion Partners with PRIA Healthcare to Advance Reimbursement and Commercial Adoption of Its AI-Powered Nociscan Platform

Aclarion, a healthcare technology company, has partnered with PRIA Healthcare to launch a Market Access Program aimed at advancing reimbursement and commercial adoption of its AI-driven Nociscan platform for chronic low back pain. Building on successful payer approvals in the UK, this initiative seeks to streamline U.S. reimbursement processes and …

17 Education & Technology Group Inc. to Report First Quarter 2026 Unaudited Financial Results on June 16, 2026

17 Education & Technology Group Inc. to Report First Quarter 2026 Unaudited Financial Results on June 16, 2026

17 Education & Technology Group Inc., a leading Chinese education technology company listed on NASDAQ, will release its unaudited first quarter 2026 financial results on June 16, 2026, followed by a management conference call. The company specializes in data-driven teaching and learning solutions and SaaS products to facilitate digital transformati…

Bulgaria Will Halt Weapons Shipments to Ukraine, Says New Defense Minister

Bulgaria Will Halt Weapons Shipments to Ukraine, Says New Defense Minister

Bulgaria's recently formed government has declared it will stop sending arms to Ukraine. Defense Minister Dimitar Stoyanov framed the move as a preference for bolstering personnel and pursuing a negotiated settlement that includes both sides. The stance mirrors Prime Minister Rumen Radev's long-held opposition to resolving the conflict by force and…

Wolfe Research Says Market Leadership Will Stay Concentrated Into 2026

Wolfe Research Says Market Leadership Will Stay Concentrated Into 2026

Wolfe Research expects the narrow cohort of market leaders to remain dominant through 2026, attributing the pattern to fund flows, increased retail participation, rising passive assets and concentrated earnings revisions in technology, media and telecommunications. The firm noted a late-week rotation into defensive sectors, but said true broadening…

BofA Lowers REA Rating, Flags Tax Reforms as Headwind for FY27 Listings

BofA Lowers REA Rating, Flags Tax Reforms as Headwind for FY27 Listings

BofA Securities has downgraded REA Group from buy to neutral and reduced its 12-month price target to A$175 from A$210. The brokerage cites Australian property tax reforms scheduled to take effect on July 1, 2027 - notably the removal of negative gearing for established homes and changes to capital gains tax - as likely to extend holding periods fo…

Bank of America Recommends Shorting CHF/JPY Ahead of BoJ Meeting

Bank of America Recommends Shorting CHF/JPY Ahead of BoJ Meeting

Bank of America on Tuesday recommended selling the Swiss franc versus the Japanese yen at 201.15, setting a downside target of 190.0 and a stop at 206.5. The bank pointed to uneven upside and downside risks tied to the Bank of Japan's upcoming policy meeting on June 16, ongoing Swiss National Bank statements and evidence of modest SNB intervention,…

Lands’ End Announces First Quarter Fiscal 2026 Results

Lands’ End Announces First Quarter Fiscal 2026 Results

Lands’ End, Inc. announced its first quarter fiscal 2026 results highlighting a temporary operational disruption due to U.S. distribution center upgrades which led to an 8.5% revenue decrease. Despite this, the company showed underlying momentum with increased consumer traffic and strong European growth. A joint venture with WHP Global has improved…

Kuwait Resumes Exports to Asian Refiners as Hormuz Transits Appear to Reopen

Kuwait Resumes Exports to Asian Refiners as Hormuz Transits Appear to Reopen

Kuwait is offering crude oil cargoes to refiners in Asia for the first time since the Iran war began, with at least 4 million barrels of its main export grade being shipped on two very large crude carriers. The move signals a partial return of flows through the Strait of Hormuz amid stepped-up U.S. transit coordination and parallel sales from other…